Nebulized tobramycin to prevent lung infection in ventilated patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether inhaling an antibiotic called tobramycin can prevent a serious lung infection in patients who need a breathing tube. It may help people at higher risk for difficult-to-treat infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been on a breathing tube (ventilator) for at least 3 days and likely need it for at least 3 more days
- You have at least one risk factor for a drug-resistant infection, such as recent antibiotic use, being in the hospital for 5+ days, or having a weakened immune system
- You do not have a current lung infection or a known allergy to tobramycin
- Your kidneys are working well enough, unless you are on dialysis
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to predict how well patients with a ventilator-associated lung infection will respond to treatment. It uses two bronchoscopy samples to track bacteria levels and guide better care.
This trial tests if giving a medication (colistin) both through an IV and as a mist you breathe in works better for lung infections caused by bacteria that are hard to treat with standard antibiotics. It may help patients who have these tough bacteria and are in the hospital.
This study tests whether giving inhaled antibiotics based on a patient's own airway bacteria can prevent ventilator-associated pneumonia (a lung infection from the breathing tube) in intensive care patients. It may help reduce infections in people who need a breathing tube for more than three days.
This trial tests whether an inhaled antibiotic (amikacin) can help clear a lung infection called ventilator-associated tracheobronchitis in patients who are on a breathing machine. It may reduce infection and improve recovery.
This trial tests whether adding an inhaled antibiotic (amikacin) to standard IV antibiotics can better treat a serious lung infection (pneumonia caused by Gram-negative bacteria) in patients on a heart-lung machine (ECMO) and a breathing tube. If you or your loved one is on ECMO and has this type of pneumonia, this study may offer a new treatment approach.
This trial tests whether using non-invasive suctioning methods (without needing to disconnect the breathing tube) can lower the risk of lung infections in critically ill patients who need a breathing tube. It may help reduce the chance of pneumonia during intensive care.
Hear when a new Pneumonia, Ventilator-Associated trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.